Current role of ultrasound for the management of hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 14, Issue 11, 2008, Pages 1710-1719

  Maruyama, Hitoshi ^a   Yoshikawa, Masaharu ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast agent; Hepatocellular carcinoma; Liver; Surveillance; Treatments; Ultrasound

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; IODINATED POPPYSEED OIL; PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVUE;

ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL RATE; SURVIVAL TIME;

EID: 41849130996     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1710     Document Type: Review

References (122)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 271-285
2. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15: 948-963
3. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-237
4. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-687
5. Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR Am J Roentgenol 1990; 155: 49-54
6. Kremkau FW. Diagnostic ultrasound: Principles and Instruments. 4th edition. Philadelphia: WB Saunders, 1993
7. Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001; 11: 1578-1593
8. Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R. Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 1998; 171: 1203-1206
9. Hann LE, Bach AM, Cramer LD, Siegel D, Yoo HH, Garcia R. Hepatic sonography: comparison of tissue harmonic and standard sonography techniques. AJR Am J Roentgenol 1999; 173: 201-206
10. Whittingham TA. Tissue harmonic imaging. Eur Radiol 1999; 9 Suppl 3: S323-S326
11. Taylor KJ, Ramos I, Morse SS, Fortune KL, Hammers L, Taylor CR. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987; 164: 643-647
12. Nino-Murcia M, Ralls PW, Jeffrey RB Jr, Johnson M. Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol 1992; 159: 1195-1197
13. Choi BI, Kim TK, Han JK, Chung JW, Park JH, Han MC. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology 1996; 200: 55-58
14. Lencioni R, Pinto F, Armillotta N, Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996; 201: 353-358
15. Gaiani S, Volpe L, Piscaglia F, Bolondi L. Vascularity of liver tumours and recent advances in doppler ultrasound. J Hepatol 2001; 34: 474-482
16. Mitchell DG. Color Doppler imaging: principles, limitations, and artifacts. Radiology 1990; 177: 1-10
17. Foley WD, Erickson SJ. Color Doppler flow imaging. AJR Am J Roentgenol 1991; 156: 3-13
18. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 1994; 190: 853-856
19. Gramiak R, Shah PM. Echocardiography of the normal and diseased aortic valve. Radiology 1970; 96: 1-8
20. Matsuda Y, Yabuuchi I. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 1986; 161: 701-705
21. Kudo M, Tomita S, Tochio H, Mimura J, Okabe Y, Kashida H, Hirasa M, Ibuki Y, Todo A. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992; 182: 155-160
22. Schlief R, Staks T, Mahler M, Rufer M, Fritzsch T, Seifert W. Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990; 7: 61-64
23. Goldberg BB. Ultrasound contrast agents. London: Martin Dunitz Ltd, 1997: 169
24. Nelson TR, Pretorius DH. Three-dimensional ultrasound imaging. Ultrasound Med Biol 1998; 24: 1243-1270
25. Downey DB, Fenster A, Williams JC. Clinical utility of three-dimensional US. Radiographics 2000; 20: 559-571
26. Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol 2003; 76: 590-599
27. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, Chuang CN, Yang PC, Wang TH. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-266
28. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003; 39: 1076-1084
29. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-278
30. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328: 1802-1806
31. Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S. Daniele B, Curley SA. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa. fetoprotein. Ann Surg Oncol 1999; 6: 178-185
32. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 2000; 95: 1036-1040
33. Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001; 16: 553-559
34. Larcos G, Sorokopud H, Berry G, Farrell GC. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol 1998; 171: 433-435
35. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432-438
36. Chalasani N, Horlander JC Sr, Said A, Hoen H, Kopecky KK, Stockberger SM Jr, Manam R, Kwo PY, Lumeng L. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94: 2988-2993
37. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403
38. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000; 95: 1535-1538
39. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 2003; 226: 533-542
40. Tanaka S, Kitamura. T, Nakanishi K, Okuda S, Yamazaki H, Hiyama T, Fujimoto I. Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer 1990; 66: 2210-2214
41. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137
42. Solmi L, Primerano AM, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. Am J Gastroenterol 1996; 91: 1189-1194
43. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78: 977-985
44. Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg 1998; 227: 513-518
45. Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, Colombo M. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 1999; 29: 1704-1707
46. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259
47. Sangiovanni A, Del Ninno E, Fasard P, De Fazio C, Ronchi G, Romeo R, Morabito A, De Franchis R, Colombo M. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014
48. Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004; 99: 1470-1476
49. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
50. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990; 154: 509-514
51. Kudo M, Tomita S, Tochio H, Kashida H, Hirasa M, Todo A. Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 1991; 179: 377-382
52. Golli M, Mathieu D, Anglade MC, Cherqui D, Vasile N, Rahmouni A. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology 1993; 187: 113-117
53. Numata K, Tanaka K, Kiba T, Saito S, Ikeda M, Hara K, Tanaka N, Morimoto M, Iwase S, Sekihara H. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001; 20: 89-98
54. Giorgio A, Ferraioli G, Tarantino L, de Stefano G, Scala V, Scarano F, Coppola C, Del Viscovo L. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 2004; 183: 1319-1326
55. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34
56. Blomley M, Albrecht T, Cosgrove D, Jayaram V, Butler-Barnes J, Eckersley R. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998; 351: 568
57. Marelli C. Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection. Eur Radiol 1999; 9 Suppl 3: S343-S346
58. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35: 80-85
59. Maruyama H, Matsutani S, Saisho H, Mine Y, Yuki H, Miyata K. Different behaviors of microbubbles in the liver: time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity. Ultrasound Med Biol 2004; 30: 1035-1040
60. von Herbay A, Vogt C, Haussinger D. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002; 179: 1273-1279
61. Bryant TH, Blomley MJ, Albrecht T, Sidhu PS, Leen EL, Basilico R, Pilcher JM, Bushby LH, Hoffmann CW, Harvey CJ, Lynch M, MacQuarrie J, Paul D, Cosgrove DO. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004; 232: 799-809
62. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53: 401-405
63. von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-1568
64. Nicolau C, Vilana R, Catalá V, Bianchi L, Gilabert R, García A, Brú C. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186: 158-167
65. Kim SH, Lee JM, Lee JY, Han JK, An SK, Han CJ, Lee KH, Hwang SS, Choi BI. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol 2005; 184: 1077-1084
66. Kim SR, Maekawa Y, Ninomiya T, Imoto S, Matsuoka T, Ando K, Mita K, Ku K, Koterazawa T, Nakajima T, Fukuda K, Yano Y, Nakaji M, Kudo M, Kim KL Hirai M, Hayashi Y. Multiple hypervascular liver nodules in a heavy drinker of alcohol. J Gastroenterol Hepatol 2005; 20: 795-799
67. Maruyama H, Matsutani S, Kondo F, Yoshizumi H, Kobayashi S, Okugawa H, Ebara M, Saisho H. Ring-shaped appearance in liver-specific image with Levovist: a characteristic enhancement pattern for hypervascular benign nodule in the liver of heavy drinkers. Liver Int 2006; 26: 688-694
68. Amano S, Ebara M, Yajima T, Fukuda H, Yoshikawa M, Sugiura N, Kato K, Kondo F, Matsumoto T, Saisho H. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003; 18: 273-279
69. Sakabe K, Yamamoto T, Kubo S, Hirohashi K, Hamuro M, Nakamura K, Inoue Y, Kaneda K, Suehiro S. Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma. Dig Surg 2004; 21: 413-420
70. Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Ojima H. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens. Intervirology 2004; 47: 199-208
71. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005; 25: 16-27
72. Terminology for hepatic allograft rejection. International Working Party. Hepatology 1995; 22: 648-654
73. Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, Oldani S, Cotichini R, Roncalli M. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003; 39: 208-214
74. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24: 807-812
75. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, Murata M, Shibata K, Zushi S, Kurokawa M, Yonezawa T, Kawata S, Takamura M, Nagano H, Sakon M, Monden M, Wakasa K, Nakamura H. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205-212
76. Quaglia A, Bhattacharjya S, Dhillon AP. Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma. Histopathology 2001; 38: 167-174
77. Roncalli M. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 2004; 10: S9-S15
78. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34
79. Takayasu K, Muramatsu Y, Mizuguchi Y, Okusaka T, Shimada K, Takayama T, Sakamoto M. CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. AJR Am J Roentgenol 2006; 187: 454-463
80. Ohto M, Karasawa E, Tsuchiya Y, Kimura K, Saisho H, Ono T, Okuda K. Ultrasonically guided percutaneous contrast medium injection and aspiration biopsy using a renal-time puncture transducer. Radiology 1980; 136: 171-176
81. Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, Fornari F, Del Vecchio Blanco C, de Sio I. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004; 53: 1356-1362
82. Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B, Moutardier V, Farges O, Valla D. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35: 254-258
83. Nakashima T, Kojiro M. Hepatocellular carcinoma. Tokyo: Springer-Verlag, 1987: 105-115
84. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, Kondo F, Kondo Y. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1990; 5: 616-626
85. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-929
86. Redvanly RD, Chezmar JL, Strauss RM, Galloway JR, Boyer TD, Bernardino ME. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy. Radiology 1993; 188: 283-285
87. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3: 636-644
88. Solbiati L, Goldberg SN, lerace T, Livraghi T, Meloni F, Dellanoce M, Sironi S, Gazelle GS. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-373
89. Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, Yoshino M, Moriyama N, Sugita M. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997; 27: 251-257
90. Lencioni R, Bartolozzi C, Caramella D, Paolicchi A, Carrai M, Maltinti G, Capria A, Tafi A, Conte PF, Bevilacqua G. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995; 76: 1737-1746
91. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661
92. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
93. Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, Perrotta A, Farella N, Aloisio V, Mariniello N, Coppola C, Francica G, Ferraioli G. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 2003; 181: 479-484
94. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464
95. Takayasu K, Muramatsu Y, Asai S, Muramatsu Y, Kobayashi T. CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminary study. AJR Am J Roentgenol 1999; 173: 1219-1224
96. Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am J Gastroenterol 2000; 95: 2102-2106
97. Schweiger GD, Brown BP, Pelsang RE, Dhadha RS, Barloon TJ, Wang G. CT fluoroscopy: technique and utility in guiding biopsies of transiently enhancing hepatic masses. Abdom Imaging 2000; 25: 81-85
98. Shibata T, Iimuro Y, Yamamoto Y, Ikai I, Itoh K, Maetani Y, Ametani F, Kubo T, Konishi J. CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US. Radiology 2002; 223: 115-120
99. Kickuth R, Laufer U, Hartung G, Gruening C, Stueckle C, Kirchner J. 3D CT versus axial helical CT versus conventional tomography in the classification of acetabular fractures: a ROC analysis. Clin Radiol 2002; 57: 140-145
100. Solomon SB, Bohlman ME, Choti MA. Percutaneous gadolinium injection under MR guidance to mark target for CT-guided radiofrequency ablation. J Vasc Interv Radiol 2002; 13: 419-421
101. Maruyama H, Kobayashi S, Yoshizumi H, Okugawa H, Akiike T, Yukisawa S, Fukuda H, Matsutani S, Ebara M, Saisho H. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. Clin Radiol 2007, 62: 668-675
102. Bartolozzi C, Lencioni R, Ricci P, Paolicchi A, Rossi P, Passariello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209: 387-393
103. Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 181: 57-63
104. Meloni MF, Goldberg SN, Livraghi T, Calliada F, Ricci P, Rossi M, Pallavicini D, Campani R. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001; 177: 375-380
105. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Lee JY, Paik SW, Koh KC, Lee JH. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 558-563
106. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, Lee JY, Jeon YH, Lee J, Lee SJ, Lim JH. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56: 66-73
107. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999; 211: 643-649
108. Cioni D, Lencioni R, Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 2000; 10: 1570-1575
109. Morimoto M, Shirato K, Sugimori K, Kokawa A, Tomita N, Saito T, Imada T, Tanaka N, Nozawa A, Numata K, Tanaka K. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003; 181: 65-69
110. Pompili M, Riccardi L, Covino M, Barbaro B, Di Stasi C, Orefice R, Gasbarrini G, Rapaccini GL. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int 2005; 25: 954-961
111. Minami Y, Kudo M, Kawasaki T, Kitano M, Chung H, Maekawa K, Shiozaki H. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 180: 703-708
112. Lim HS, Jeong YY, Kang HK, Kim JK, Park JG. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. AJR Am J Roentgenol 2006; 187: W341-W349
113. Rankin RN, Fenster A, Downey DB, Munk PL, Levin MF, Vellet AD. Three-dimensional sonographic reconstruction: techniques and diagnostic applications. AJR Am J Roentgenol 1993; 161: 695-702
114. Picot PA, Rickey DW, Mitchell R, Rankin RN, Fenster A. Three-dimensional colour Doppler imaging. Ultrasound Med Biol 1993; 19: 95-104
115. Downey DB, Fenster A. Vascular imaging with a three-dimensional power Doppler system. AJR Am J Roentgenol 1995; 165: 665-668
116. Ritchie CJ, Edwards WS, Mack LA, Cyr DR, Kim Y. Three-dimensional ultrasonic angiography using power-mode Doppler. Ultrasound Med Biol 1996; 22: 277-286
117. Acar P, Dulac Y, Taktak A, Abadir S. Real-time three-dimensional fetal echocardiography using matrix probe. Prenat Diagn 2005; 25: 370-375
118. Monaghan MJ. Role of real time 3D echocardiography in evaluating the left ventricle. Heart 2006; 92: 131-136
119. Ohto M, Kato H, Tsujii H, Maruyama H, Matsutani S, Yamagata H. Vascular flow patterns of hepatic tumors in contrast-enhanced 3-dimensional fusion ultrasonography using plane shift and opacity control modes. J Ultrasound Med 2005; 24: 49-57
120. Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR, Cranston D. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 2004; 42: 931-935
121. Li CX, Xu GL, Jiang ZY, Li JJ, Luo GY, Shan HB, Zhang R, Li Y. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 2004; 10: 2201-2204
122. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005; 235: 659-667